Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
DDDD,
It may be true that these countries don’t have the financial resources of a first world country. But the number of vials they can afford to buy is not zero. CYDY does not need to sell a a lot of doses to have a big impact on their overall financial situation. $100M in revenue buys a lot of financial runway to more approvals for CYDY.
Rockleo,
There is no doubt that Dr. Patterson’s ability to communicate anything Leronlimab related beats NP’s word salad hands down.
NP losing Rockleo is like Lyndon Johnson losing Walter Cronkite.
Not a good sign for NP!
Totally agree.
If all of the people who don’t get an annual flu vaccine can be considered “anti-vaxxers”, then we live in an “anti-vaxxer” majority country.
The truth is none of us know for sure. Why speculate on a topic where you have no first hand knowledge?
I heard mgt shares are locked up until judge signs off on case settlement for unjust enrichment. Not sure if it applies to wifey, but I believe it does.
Maybe NP had a dentist appointment. It is just the regular update he said he would give.
It feels like people are turning this delay into the Da Vinci Code.”
Why postpone the CC?
If there were any available shares left to short.
This would be a good time for a short attack.
The FDA has all of the raw data as well. If they don’t know, they can easily confirm it.
These paid for ad articles are bordering on false information. I'm sure the FDA would take issue with a reaction to something they haven't seen yet.
Until we see the final results, no one knows the if these numbers will hold.
The DSMC said lenzilumab had 37% efficacy during the interim analysis. The 37% efficacy was with all of the patients, not a 16% slice of patients like leronlimab.
How do you know that?
Nader was told by the FDA to do an additional 140 patient cohort because an EUA was not in play.
Since you have seem to have the time to focus on CYDY, perhaps you could reach out to the doctor and update us on his current thoughts.
You have previously said that Dr. Umang Khetarpal introduced you to leronlimab and that he is a brilliant doctor. Umang has been silent about leronlimab for months after being quite vocal previously. What does Umang think about trial results?
Really?
Doctors are nortoriously bad at science
I totally agree with all points.
Getting through the regulatory process is time consuming and complex.
However, telling investors what you have and have not done can be done by a 5th grader.
I want to believe that is true. But this has the feel of another NP nothing burger.
She has an interest in therapeutics.
She had Fauci on her show recently and was trying to get him to explain his reluctance in supporting therapeutics. At the end he basically came out and said he wanted a pill like they used in HIV. Nothing else was practical in his mind. She did get him to acknowledge there was a subQ option.
I would also include Rachel Maddow in any letters to the FDA or congressional representatives.
EMAIL US: Rachel@msnbc.com. TWEET US: @MaddowBlog
JDF,
NP indicated that the information would be published in medical journals soon.
He has already shared a lot of the summary data. I assume the additional will just support what we have already been told.
Is there a reason you need to see more data now?
3X,
So the $15K you saved by not buying the shares at $0.30, is somehow a smart move considering it would be worth $200K+ today?
Not sure I follow your logic on how that is good for your children’s inheritance.
Kgromax,
Can you please share your analysis. If your work shows CYDY with a 99% likelihood of failure, it would be nice to see how you arrived at that conclusion.
Are you referring to our new “Did The Above Get Your Attention?” section?
It seems so fair and balanced.
Wow!
A new sherif is in town.
I’m thrilled to see that Scooter and daemon57 are now moderators.
Thank you both for stepping up to the challenge.
Isn’t HGEN at $4 pre-reverse split?
With CYDY at $6, that doesn’t seem like price parity.
Am I missing something?
Welcome back misiu!
We missed you.
....and a great response to the Cokadoodledue post.
Dante 4 minutes ago
Best post I’ve ever read on this board thank u....NADARS A JUNK YARD DOG!
He’s never full!
Godspeed
Great Post From YMB
Cokadoodledue 4 hours ago
Here is my response to someone. It deserves it's own post.
@FactChecker, why should I convince you to do anything? I've done MY DD!! As far as NP is concerned, I've always supported him. Some, may not like his personality, his accent or some may have just had chips on their shoulders because things didn't happen as fast as they had wanted them to. As far as I'm concerned, for what he had to deal with, he has shined brightly!! I stood by him 100%. I continue to do so. And, as long as he keeps performing, I will always support him 100%.
As an aside, don't let disgruntled former employees, who felt that they should run the Company be your source of information. These folks can see a speck on NP's nose, but they can't see their own issues. If they didn't want to deal with him they didn't have to sell a Company to him, or choose to consult for him or whatever. He has had the FDA acting very unprofessional, in its bias against small Biotech. Remember the whole BP controversy this past year? Their studies getting done with mods. Only to authorize drugs, which were harmful, at worst, or didn't work, at best. (Remdesivir, RGEN's & LLY's mAbs, Hydrochloroquine, Convalescent Plasma). Everyone knew about Leronlimab's efficacy back in April. Yet, the only way NP could've gotten the drug quickly to the market would've resulted in partnering with BP, at a severe loss to future growth for shareholders.
Oh, and then there was the dilution. Hmm, well, first the were shorts depressing the price because of the way the FDA stuck it to the little guy. Then, you had the widow of the ex-CEO who had to be bought out (at a time when the stock price was really depressed). And, because the shorts continued to hamper efforts to raise capital at higher prices, NP was forced to dilute more. Shall I continue?
Okay, the NASDAQ. Let's see, you had all of these things happening, and then you had the former employees, mentioned above, decide to litigate against NP and its Officers. Talk about kicking someone when their down. But, it gets more complicated, perhaps by design, by those suing NP. You see, the NASDAQ doesn't like to see litigation. They also don't like to see the use of poison pills being employed. Then, of course, there's the shareholders equity. Well, you've got to appreciate the 'perfect storm', which was being orchestrated AGAINST NP. Can you see the negative synergy developing here? It's not like he was just dealing with these problems on their own. Their additive effects combined to create far greater problems for NP than the sum of their parts.
Oh, the poison pill. What is that, do you ask? The performance shares and convertibles awarded to management, which everyone was so upset over. They were 'awarded' to management in an effort to protect shareholders from a company like GILD from making a hostile takeover bid for pennies on the dollar.
But, you see, Covid came into the picture and changed EVERYTHING. Regardless of who claimed the credit for noticing Leronlimab's utility against Covid-19, it's immaterial!! Why? Because, NP still had all of those headwinds pushing against his forward progress. Despite everything, he was able to marshal the forces, and get things done. He was able to bring on thought leaders, credentialed professionals and still obtain non-dilutive financing. However, that's not all. Then, he shrewdly pitted the US FDA against 4 other countries, in an International game of chess, with a little game of chicken thrown in; just to see who flinched first. He continues to play that game. And, look! The FDA decided it wanted the data as soon as it was locked down, NOT weeks later after the Company had a chance to clean it and present it in the most pristine way. And, why? Because, IT WORKS!!! And, NP had the vision to see how it would work, back when he first took it off the shelf and blew the cobwebs off of it. After everyone told him no, NP persevered. It's BECAUSE OF NP, not in spite of him, that we are on the cusp of great things and great wealth!!!
Oh sure, those shareholders with the 8-figure share count...they were looking to sell cheap. It is of my opinion that they lack vision, conviction and courage and would have hurt the rest of the shareholders' dreams of achieving great wealth, because of their incessant complaints of NP. It is of my opinion, that these large shareholders need to shut their yaps. Because, if I didn't know any better, it would almost seem as if THEY were responsible for pumping figstain full of their own emotional hostility in an effort to have NP replaced. After all, figstain had lost his financial backing, and yet he continues to hold these hostile feelings towards NP. Ask yourself, 'why, would a self-proclaimed journalist continue to bring emotion-based arguments against the CEO, when the large short funds have already decided to go Long CYDY?' Could it be that there are others who are buttering his toast??
Chew on THAT for awhile!!
Hopester,
Does your TA show an uptrend yet for CYDY?
What is the market telling us?
I wonder what Hopester’s TA is telling him about the price of CYDY on Monday?
Since the market is all knowing, wherever we end the day will be the “correct” price.
How do you know that?
What is your source?
Can you provide a link?
All anyone cares about is the primary endpoint. We want to know how many died in each arm of the trial. They have that information. They are clearly withholding that information because it is not good.
That is one more positive boost in my confidence for the CD12 results.
All signs continue to point to significant good news in the coming weeks (unless you are short).
This document shows Leronlimab code XW013K6 is effective 1/1/21.
I don’t understand where this 1/21/21 date came from. Am I blind or did someone make a typo that keeps getting repeated?
Latane,
There are a lot of us that follow and appreciate your posts. You have more supporters than you know.
Don’t stop posting!
That also means we would only stay about $5M for about a week at the current cash burn of $2.5M per week. That would lead me to think we will uplist this week.
Chuckles,
You are the BEST!
What would we do without your great research!
I’m glad you are long.
I hope you attend our party in Vegas when the time comes. It will be great to exchange “war stories” about all of the battles in the CYDY war.
Hopester,
While there have been times that I have appreciated your thoughts and comments on CYDY, I think your arguments are getting pretty weak as we enter the end game. I hope that you take Rockleo’s advice and are long in your account. Hopefully, your employer can’t prevent you from taking a position in CYDY.
Many of us have come to enjoy you and wish you good fortune and good health in the future. May Leronlimab be there for you and your family if you ever need it.
Totally agree.
I have a number of limit orders set in the $4’s.
Come on shorts. You can do better than that! Drive it down more so we can buy and tighten the trap on you!
Misiu
Thanks for that information. That helps reinforce my belief that CYDY is the better horse to ride.
Cowtown,
You seem to show up everywhere I go. I’m looking forward to your future posts on this stock.